Previous 10 | Next 10 |
SAN CLEMENTE, Calif., March 18, 2021 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced that Company management will participate in a v...
ICU Medical, Inc. (ICUI) Q4 2020 Earnings Conference Call February 25, 2021 4:30 PM ET Company Participants John Mills - Managing Partner-ICR Vivek Jain - Chief Executive Officer & Chairman Brian Bonnell - Chief Financial Officer Conference Call Participants Matthew Mishan - KeyBanc Pete ...
The following slide deck was published by ICU Medical, Inc. in conjunction with their 2020 Q4 earnings call. For further details see: ICU Medical, Inc. 2020 Q4 - Results - Earnings Call Presentation
Image source: The Motley Fool. ICU Medical Inc (NASDAQ: ICUI) Q4 2020 Earnings Call Feb 25, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: ICU Medical Inc (ICUI) Q4 2020 Earnings Call Transcript
ICU Medical (ICUI): Q4 Non-GAAP EPS of $1.77 beats by $0.26; GAAP EPS of $1.21 beats by $0.10.Revenue of $320.5M (+1.6% Y/Y) beats by $19.83M.2021 Guidance: Adj, EBITDA of $245-$265M, and adj. EPS to be in the range of $6.50 to $7.20.Press Release For further details see: ICU Medic...
SAN CLEMENTE, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced financial results for the quarter ended December...
SAN CLEMENTE, Calif., Feb. 24, 2021 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced that Company management will present at the Raym...
SAN CLEMENTE, Calif., Feb. 04, 2021 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced the time of its fourth quarter and fiscal year 2...
ICU Medical's Plum 360™ Infusion System Receives First-Ever Best in KLAS Honor as Top-Performing Smart Pump EMR-Integrated KLAS Research recognizes Plum 360 as 2021 Best in KLAS for Smart Pump EMR-Integrated, highlighting ICU Medical's pioneering efforts to advance indust...
SAN CLEMENTE, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced that Company management will present at the J.P....
News, Short Squeeze, Breakout and More Instantly...
SAN CLEMENTE, Calif., July 24, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its second quarter 2024 earnings release and conference call. The Company will release its ...
SAN CLEMENTE, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended March 31, 2024. First Quarter 2024 Results First...
Aterian Inc. (ATER) is expected to report for Q1 2024 Dorman Products Inc. (DORM) is expected to report $0.82 for Q1 2024 Hillman Solutions Corp. (HLMN) is expected to report $0.08 for Q1 2024 Wake Forest Bancshares, Inc. (WAKE) is expected to report for quarter end 2024-03-31 Inn...